First, it was reported that the bradykinin receptor, a direct sGC activator, and its pathway components were expressed in androgen-dependent and -independent prostate cancer cell lines; however, sGC subunit expression was undetectable in these androgen-independent cells [124]. Here, SGCB is linked to prostate carcinoma.